EP
Eversept Partners Portfolio holdings
AUM
$992M
1-Year Return
2.54%
This Quarter Return
-8.54%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$884M
AUM Growth
-$85.4M
(-8.8%)
Cap. Flow
-$1.55M
Cap. Flow
% of AUM
-0.18%
Top 10 Holdings %
Top 10 Hldgs %
58.82%
Holding
75
New
11
Increased
23
Reduced
20
Closed
18
Top Buys
| 1 |
Syndax Pharmaceuticals
SNDX
|
$47.5M |
| 2 |
Neurocrine Biosciences
NBIX
|
$18.5M |
| 3 |
Vaxcyte
PCVX
|
$16.2M |
| 4 |
Glaukos
GKOS
|
$15.6M |
| 5 |
Community Health Systems
CYH
|
$15.2M |
Top Sells
| 1 |
GSK
GSK
|
$40.2M |
| 2 |
Inspire Medical Systems
INSP
|
$17.2M |
| 3 |
Viatris
VTRS
|
$15.8M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$12.8M |
| 5 |
Edwards Lifesciences
EW
|
$12.6M |
Sector Composition
| 1 | Healthcare | 98.66% |
| 2 | Financials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Puma Biotechnology
PBYI
$257M
| $816K | 0.08% |
275,788
-720,314
| -72% | -$2.13M |
|
52
Alector
ALEC
$285M
| $759K | 0.08% |
617,418
+417,323
| +209% | +$513K |
|
53
eHealth
EHTH
$121M
| $596K | 0.06% |
+89,220
| New | +$596K |
|
|
AUTL
54
Autolus Therapeutics
AUTL
$386M
| $533K | 0.05% |
343,947
+245,052
| +248% | +$380K |
|
55
AC Immune
ACIU
$216M
| $188K | 0.02% |
+100,752
| New | +$188K |
|
56
Absci
ABSI
$359M
| – | – |
-199,464
| Closed | -$523K |
|
57
Arcutis Biotherapeutics
ARQT
$1.94B
| – | – |
-191,158
| Closed | -$2.66M |
|
58
AstraZeneca
AZN
$254B
| – | – |
-102,661
| Closed | -$6.73M |
|
59
Danaher
DHR
$143B
| – | – |
-22,209
| Closed | -$5.1M |
|
60
DexCom
DXCM
$31.7B
| – | – |
-148,688
| Closed | -$11.6M |
|
61
Evolus
EOLS
$486M
| – | – |
-383,045
| Closed | -$4.23M |
|
|
62
Edwards Lifesciences
EW
$47.5B
| – | – |
-170,678
| Closed | -$12.6M |
|
63
Guardant Health
GH
$7.65B
| – | – |
-276,036
| Closed | -$8.43M |
|
64
Henry Schein
HSIC
$8.22B
| – | – |
-80,303
| Closed | -$5.56M |
|
65
Medpace
MEDP
$13.6B
| – | – |
-19,049
| Closed | -$6.33M |
|
|
MREO
66
Mereo BioPharma
MREO
$275M
| – | – |
-777,890
| Closed | -$2.72M |
|
67
SPDR S&P 500 ETF Trust
SPY
$662B
| – | – |
0
| – | – |
|
68
Supernus Pharmaceuticals
SUPN
$2.55B
| – | – |
-105,581
| Closed | -$3.82M |
|
69
iShares 20+ Year Treasury Bond ETF
TLT
$48.1B
| – | – |
0
| – | – |
|
|
TSVT
70
DELISTED
2seventy bio
TSVT
| – | – |
-1,003,678
| Closed | -$2.95M |
|
|
71
Viatris
VTRS
$12B
| – | – |
-1,272,102
| Closed | -$15.8M |
|
72
Xenon Pharmaceuticals
XENE
$2.98B
| – | – |
-155,540
| Closed | -$6.1M |
|
73
Dentsply Sirona
XRAY
$2.86B
| – | – |
-139,656
| Closed | -$2.65M |
|
74
Zai Lab
ZLAB
$3.34B
| – | – |
-102,930
| Closed | -$2.7M |
|
|
PDCO
75
DELISTED
Patterson Companies, Inc.
PDCO
| – | – |
-146,051
| Closed | -$4.51M |
|